PEPTIDES FOR SALE

BPC-157 + TB-500: Why Researchers Study This Stack Together In peptide research circles, the combination of BPC-157 and TB-500 has earned a nickname: the Wolverine Stack. The name comes from the idea that together, these two peptides cover tissue repair and recovery from multiple angles simultaneously. Understanding why researchers are drawn to this combination requires looking at what each peptide does on its own first. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is BPC-157? BPC-157 stands for Body Protection Compound 157. It’s a synthetic pentadecapeptide — a 15 amino acid sequence — derived from a protein found in human gastric juice. Despite its gut origin, research has shown BPC-157 to have effects that extend well beyond the gastrointestinal system. Studies in animal models have documented BPC-157’s influence on: Tendon and ligament repair: Research suggests BPC-157 upregulates growth hormone receptors in tendon fibroblasts, potentially accelerating repair timelines in tendon injury models. Angiogenesis: Studies show BPC-157 promotes the formation of new blood vessels, which researchers believe is central to its repair-supporting effects. Gut integrity: In gastrointestinal research, BPC-157 has shown protective effects on the intestinal lining in inflammatory and ulcer models. Nerve tissue: Some research suggests neuroprotective properties, with studies showing benefits in nerve crush injury models. What Is TB-500? TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring peptide found in high concentrations in blood platelets and wound fluids. Its primary research interest lies in its relationship with actin — a structural protein critical to cell movement, repair, and organization. Research on TB-500 has shown: Cell migration: TB-500 promotes the migration of cells to injury sites, a critical early step in tissue repair. Muscle and cardiac repair: Animal studies have explored TB-500’s role in cardiac muscle recovery after injury, with researchers noting improved repair markers. Inflammation modulation: Research suggests TB-500 has anti-inflammatory properties, helping to regulate the inflammatory phase of wound healing. Flexibility and range of motion: Some research in animal models has noted reduced connective tissue inflammation and improved mobility markers. Why Researchers Combine Them: The Synergy Hypothesis BPC-157 and TB-500 appear to operate through complementary but distinct mechanisms. This is the core reason researchers study them together rather than in isolation. BPC-157 works heavily through the nitric oxide system and growth hormone receptor upregulation — it drives the structural rebuilding process at the cellular level. TB-500, meanwhile, works through actin regulation and cell migration — it mobilizes repair cells and gets them to the site of damage. Research suggests that by combining both, you’re addressing the full repair cascade: TB-500 handles the recruitment and mobilization phase while BPC-157 supports the structural rebuilding phase. Studies examining the two compounds together have shown additive effects in tendon, muscle, and gut injury models. The Wolverine Stack in Research The scientific interest in this combination goes beyond convenience. Some researchers theorize that the two peptides may even have a mild synergistic effect — meaning together they produce results greater than the sum of their parts. While the research is still evolving, the number of studies now examining this combination is growing steadily. For researchers working in tissue repair, injury modeling, or recovery science, the BPC-157 + TB-500 combination represents one of the most well-characterized research pairings in the peptide field. Get the Wolverine Stack for Your Lab PeptiVigor offers BPC-157 5mg/TB-500 5mg as a convenient combination for research protocols. Both peptides are produced to high purity standards. Visit peptivigor.com to order today. Use code LABVIP1 at checkout for 15% off your entire order.

Tirzepatide Research: Why the Dual GLP-1/GIP Agonist Is Getting So Much Attention The peptide research world has been buzzing about tirzepatide — and if you haven’t looked into it yet, now is a great time. This compound represents a meaningful step forward in how researchers approach metabolic signaling. Instead of targeting one receptor pathway, tirzepatide engages two simultaneously, opening up research questions that simply couldn’t be asked with earlier GLP-1 compounds. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is Tirzepatide as a Research Compound? Tirzepatide is a dual agonist designed to activate both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It’s a synthetic peptide engineered with a fatty acid chain that extends its half-life, making it well-suited for research protocols that need sustained receptor engagement over several days. What makes tirzepatide structurally interesting is that it’s not simply two peptides combined — it’s a single molecule designed to bind both receptor types with meaningful affinity, particularly with a strong lean toward GIP agonism alongside GLP-1 activity. The Dual GLP-1 and GIP Receptor Mechanism GLP-1 and GIP are both incretin hormones — hormones released from the gut after eating that help regulate blood sugar and metabolism. Individually, each has a well-documented receptor pathway: GLP-1 receptors are found in the pancreas, brain, gut, and heart. Activation is associated with insulin secretion, appetite suppression, and slowed gastric emptying. GIP receptors are found in the pancreas, fat tissue, and brain. Research suggests GIP signaling influences fat storage, insulin sensitivity, and energy balance in ways that differ meaningfully from GLP-1. The research hypothesis behind dual agonism is that combining these two pathways could produce metabolic effects greater than either alone — and early studies are supporting that hypothesis. What Research Shows: Dual Agonism vs. Single Agonism Head-to-head research comparing tirzepatide to GLP-1-only agonists like semaglutide has produced some striking data: Studies show tirzepatide produces significantly greater reductions in body weight markers in animal and human research models compared to GLP-1-only approaches at equivalent doses. Research suggests the GIP component may play an important role in fat tissue metabolism — some studies indicate GIP receptor activation improves adipocyte insulin sensitivity, which complements GLP-1’s effects on appetite and glucose. Researchers have also noted that the GIP component appears to reduce some of the gastrointestinal side effects associated with strong GLP-1 agonism alone, making dual agonism an interesting tolerability study subject. Why Researchers Find the Dual Mechanism Compelling Single-pathway interventions have a ceiling. When you activate only one receptor system, you’re limited to what that system can accomplish. The dual mechanism of tirzepatide gives researchers a tool to ask: what happens when you coordinate two complementary metabolic signals at once? The early answer, according to published research, is that the effects are additive and possibly synergistic in some metabolic pathways. This has made tirzepatide one of the most cited compounds in obesity and metabolic disease research in recent years. Additionally, the GIP receptor’s role in the central nervous system is an emerging research frontier. Some studies suggest GIP signaling in the brain influences food reward and dopaminergic activity — a different mechanism from GLP-1’s hypothalamic effects. Researchers studying the neuroscience of appetite are paying close attention. Start Your Dual Agonist Research PeptiVigor carries Tirzepatide 10mg for laboratory research applications. Our compounds are held to high purity standards so your protocols start from a reliable baseline. Head to peptivigor.com to browse our metabolic research catalog. Apply code LABVIP1 for 15% off your first order.

Semaglutide for Research: What Scientists Are Learning About GLP-1 in 2026 If you’ve followed metabolic research over the past few years, one name keeps showing up in study after study: semaglutide. This compound has become one of the most scrutinized molecules in modern metabolic science, and for good reason. Researchers are uncovering new layers to how it interacts with the body’s hormonal systems — and the findings are genuinely fascinating. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is Semaglutide as a Research Compound? Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone produced in the intestines in response to food intake. What makes semaglutide particularly useful in research is its extended half-life. Unlike native GLP-1, which breaks down within minutes, semaglutide is engineered to resist enzymatic degradation, giving researchers a much wider observation window per experiment. In research settings, semaglutide is used to study GLP-1 receptor activity in detail — something that wasn’t easily possible when the native peptide degraded so quickly. How GLP-1 Receptor Signaling Works GLP-1 receptors are found throughout the body — in the pancreas, brain, heart, and gut. When a GLP-1 agonist like semaglutide binds to these receptors, it triggers a cascade of signaling events. In pancreatic cells, studies show this leads to glucose-dependent insulin secretion. In the brain — particularly in regions like the hypothalamus and brainstem — researchers have observed strong effects on appetite regulation and satiety signaling. This broad receptor distribution is part of why GLP-1 research has expanded so rapidly beyond just glucose metabolism. What Research Shows About Metabolic Effects Peer-reviewed studies involving semaglutide have documented several notable metabolic observations: Glucose regulation: Research suggests semaglutide enhances insulin secretion in a glucose-dependent manner, meaning the signal only fires when glucose is present — a mechanism researchers find elegant and precise. Gastric motility: Studies show a measurable slowing of gastric emptying, which researchers believe contributes to prolonged satiety signals in animal models. Lipid metabolism: Some research indicates effects on fatty acid oxidation and lipid storage pathways, making it a subject of interest in obesity and fatty liver research. Cardiovascular markers: A growing body of research is examining GLP-1 receptor agonism and cardiovascular outcomes, including inflammation markers and endothelial function. Appetite Signaling Studies One of the most active research areas around semaglutide involves appetite signaling in the central nervous system. Research suggests that GLP-1 receptor activation in the hypothalamus reduces neuropeptide Y (NPY) signaling — one of the brain’s primary hunger drivers. Studies in animal models consistently show reduced caloric intake, which researchers attribute to both peripheral and central receptor activity. Researchers studying food reward behavior have also noted effects on dopaminergic pathways, suggesting that GLP-1 agonism may alter the motivational component of eating, not just the physiological hunger signal. Why Semaglutide Remains a Top Research Compound in 2026 The scientific community’s interest in semaglutide hasn’t slowed — it’s accelerating. New research is exploring its potential roles in neuroinflammation, liver disease models, and even addiction research. Its well-characterized receptor profile and long half-life make it a dependable tool for studying GLP-1 biology across multiple organ systems. For researchers building out metabolic or obesity-related study protocols, semaglutide offers one of the most studied and reproducible frameworks available in peptide science today. Source Your Research Compound with Confidence PeptiVigor offers Semaglutide 5mg for qualified research purposes. Each batch is produced to meet rigorous purity standards, giving your lab a reliable foundation for GLP-1 research. Visit peptivigor.com to explore our full catalog of research peptides. Use code LABVIP1 at checkout for 15% off your order.

Lipo-C+: The Lipotropic Compound Blend Researchers Use for Fat Metabolism Studies Not every research compound in the peptide world is a single molecule. Some of the most useful tools in metabolic research are strategic blends designed to support multiple pathways simultaneously. Lipo-C+ is exactly that — a lipotropic compound blend that brings together several well-researched ingredients to support fat metabolism research in a single, convenient formulation. What Are Lipotropic Compounds? The term “lipotropic” comes from Greek roots meaning “fat-moving.” Lipotropic compounds are substances that support the mobilization, transport, and metabolism of fats — particularly in the liver, which is the central hub of lipid processing in the body. The concept of lipotropic agents has been in nutritional and metabolic research since the mid-20th century, when researchers first observed that certain nutrients — particularly methionine and choline — were essential for preventing fat accumulation in the liver. Over time, a consistent set of core lipotropic compounds has emerged that appears repeatedly in fat metabolism research. What’s in a Lipo-C+ Formula? Lipo-C+ formulations typically include a combination of the following well-studied components: Methionine: An essential amino acid that plays a critical role in fat metabolism by supporting the liver’s ability to process and export fats. Research shows it is involved in methylation reactions essential to lipid metabolism. Inositol: A naturally occurring carbohydrate that research has linked to fat metabolism and insulin signaling. Studies show inositol may support the liver’s ability to process fats and reduce fat accumulation. Choline: An essential nutrient that is a precursor to phosphatidylcholine — a key component of cell membranes and bile, which is required for fat digestion. Research shows choline deficiency leads to hepatic (liver) fat accumulation. B Vitamins (B1, B2, B3, B5, B6, B12): The B vitamin complex is deeply involved in energy metabolism. Research shows B vitamins serve as coenzymes in virtually every step of energy production from carbohydrates, proteins, and fats. B12 in particular has been studied in the context of metabolic energy and fat metabolism support. L-Carnitine: Perhaps the most directly fat-metabolism-focused ingredient in the blend. Research shows L-carnitine transports long-chain fatty acids into mitochondria, where they are burned for energy. Without adequate L-carnitine, fatty acids cannot efficiently enter the mitochondria for oxidation. What Does Research Show About Fat Metabolism Support? Each individual component in a Lipo-C+ blend has its own research supporting its role in fat metabolism: Studies show that choline and methionine deficiency leads directly to hepatic steatosis (fatty liver) in animal models, confirming their foundational role in liver fat processing. Research in rodent models has shown that L-carnitine supplementation increases fatty acid oxidation — the process of burning fat for fuel — particularly during caloric restriction and exercise. Inositol research has shown connections to insulin resistance and fat metabolism in human trials. B vitamin research consistently shows their essential role as cofactors in the metabolic pathways that convert stored fat into usable energy. Why Researchers Use Lipotropic Blends Alongside Peptide Protocols In research settings where peptides like AOD-9604, MOTS-c, or other metabolic compounds are being studied for fat metabolism effects, lipotropic blends like Lipo-C+ are sometimes used alongside them. The rationale is straightforward: if a research compound is stimulating lipolysis (the release of stored fat), having the supporting metabolic infrastructure in place — adequate choline for liver fat transport, L-carnitine for mitochondrial fat oxidation, B vitamins for energy pathway cofactors — may provide a more complete picture of fat metabolism dynamics. Lipotropic blends also offer researchers a practical way to study the combined effects of multiple well-characterized metabolic support compounds in a single, standardized formulation — making Lipo-C+ a versatile addition to any fat metabolism research protocol. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. Explore Lipo-C+ and all of PeptiVigor’s research compounds at peptivigor.com — check out Lipo-C+ 10ml. Use code LABVIP1 at checkout to save 15% on your entire order.

Thymosin Alpha-1: The Immune Research Peptide With Decades of Study Behind It When researchers look for a peptide with serious scientific credibility in the immune space, Thymosin Alpha-1 consistently comes up. This is not a newcomer — it has been studied for more than four decades and has received regulatory approval in multiple countries for immune-related conditions. For researchers who want an immune-modulating peptide with a deep research foundation, Thymosin Alpha-1 stands alone. What Is Thymosin Alpha-1? Thymosin Alpha-1 (Ta1) is a 28-amino acid peptide naturally derived from thymosin fraction 5, a mixture of peptides extracted from thymus tissue. It was first isolated and characterized in the 1970s by Allan Goldstein and colleagues — a discovery that opened an entirely new field of thymic peptide research. The thymus gland plays a central role in immune system development, particularly in the maturation of T-cells. Thymosin Alpha-1 appears to be one of the primary signaling molecules through which the thymus influences T-cell development and immune activity — even after the thymus has atrophied, as it does in adulthood. Decades of Immune Research The research history of Thymosin Alpha-1 is extensive by peptide standards: It is approved as a pharmaceutical product (brand name Zadaxin) in more than 35 countries, where it is used for chronic hepatitis B, hepatitis C, and as an immune adjuvant in certain cancer treatment protocols. It has been studied in clinical trials for a wide range of immune-related conditions including HIV, sepsis, malignancies, and vaccine enhancement. Research has been published in major peer-reviewed journals over more than four decades — making it one of the most extensively documented peptides in immune research. What Studies Show About Immune Modulation and T-Cell Activity T-cell maturation: Research shows Thymosin Alpha-1 promotes the differentiation and maturation of T-cells. It appears to drive naive T-cells toward Th1 responses, which are important for fighting infections and abnormal cells. Natural killer (NK) cell activity: Studies show increased NK cell activity in subjects treated with Thymosin Alpha-1 — cells that play a frontline role in identifying and eliminating threats. Dendritic cell function: Research has shown that Thymosin Alpha-1 enhances dendritic cell activity, improving antigen presentation and the ability of the immune system to mount targeted responses. Immune restoration in compromised models: Studies in animal models and human trials have consistently shown that Thymosin Alpha-1 can restore immune function in subjects with suppressed immune systems. Anti-inflammatory balance: Research also shows Thymosin Alpha-1 can help regulate excessive immune responses, potentially reducing harmful inflammation while supporting effective immune activity. Why Immune Researchers Find It One of the Most Studied Peptides Available The combination of a clear natural origin, a well-defined mechanism of action, and four decades of clinical and preclinical data makes Thymosin Alpha-1 exceptional in the peptide research world. Most peptides researchers work with have limited human data. Thymosin Alpha-1 has clinical trial data from multiple countries and disease contexts. For researchers studying immune aging — the decline of immune function with age, known as immunosenescence — thymic peptides like Thymosin Alpha-1 are particularly relevant. The thymus is one of the first organs to age significantly, beginning to involute as early as the mid-20s. Understanding how thymic peptides can influence immune function later in life is an important frontier in longevity research. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. Get research-grade Thymosin Alpha-1 at peptivigor.com — see Thymosin Alpha-1 5mg. Use code LABVIP1 at checkout to save 15% on your order.

AOD-9604: The Fat Loss Fragment Researchers Broke Off from HGH AOD-9604 has one of the more interesting origin stories in peptide research. It was not developed from scratch — it was extracted from human growth hormone itself. Researchers wanted to find out which part of the HGH molecule was responsible for its fat-burning effects, isolate it, and study it without everything else that comes with full HGH. What they found has made AOD-9604 one of the more focused tools in metabolic peptide research. What Is AOD-9604? AOD-9604 is a modified fragment of the C-terminal region of human growth hormone — specifically amino acids 176-191, with an additional tyrosine residue added to stabilize the peptide. The name AOD stands for “anti-obesity drug,” reflecting its original development purpose. The full HGH molecule does many things: it promotes cell growth, stimulates IGF-1 production, affects carbohydrate metabolism, and influences fat metabolism. AOD-9604 was created specifically to isolate the fat metabolism piece. Research suggests it retains HGH’s lipolytic (fat-breaking) properties without the growth-promoting or glucose-disrupting effects that come with full HGH. What Does Research Show About Lipolysis and Fat Metabolism? Lipolysis stimulation: Studies in animal models show that AOD-9604 stimulates the breakdown of fat (lipolysis) in adipose tissue. It appears to do this through the same receptor pathway as the fat-metabolism portion of HGH. Inhibition of lipogenesis: Research suggests AOD-9604 may also inhibit lipogenesis — the process by which the body converts carbohydrates into fat. This dual action (more fat burning, less fat storage) is a central focus of metabolic research with this compound. Obese rodent models: Studies in diet-induced obese mice have shown significant reductions in body fat in AOD-9604-treated subjects compared to controls, without the negative metabolic effects sometimes observed with full HGH. No effect on blood glucose or IGF-1: Unlike full HGH, studies show AOD-9604 does not significantly raise IGF-1 levels or disrupt glucose metabolism — a finding that has made it useful for researchers wanting to study fat metabolism in isolation. Why Do Researchers Study It Separately From Full HGH? Full HGH is a complex molecule with a wide range of effects across multiple systems. For researchers specifically studying fat metabolism, the broad activity of full HGH introduces too many confounding variables. AOD-9604 allows researchers to study lipolytic mechanisms with much greater specificity. Think of it as a research tool that lets scientists ask a narrower question: what happens to fat metabolism when you activate only this specific part of the HGH pathway? That kind of precision is valuable in metabolic research design. Metabolic Research Applications AOD-9604 reached Phase II and Phase III clinical trials in humans for obesity treatment — giving it one of the more substantial clinical research histories among peptides in this category. While it did not receive FDA approval for obesity treatment, the clinical data generated during those trials remains a valuable resource for metabolic researchers. Areas of ongoing study include fat distribution in aging, metabolic syndrome, and the interplay between lipolysis and energy expenditure. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. Source research-grade AOD-9604 at peptivigor.com — see AOD-9604 5mg. Use code LABVIP1 at checkout to get 15% off your order.

Hexarelin: The Potent GHRP Researchers Study for Heart and Growth Hormone Research Within the family of growth hormone releasing peptides, Hexarelin occupies a particular position: it is widely considered the most potent GHRP available for research. But potency is not the only reason researchers are interested. Hexarelin has also generated significant research interest in an area most people would not expect — cardiac function. That combination makes it one of the more versatile GHRPs in current research use. What Is Hexarelin? Hexarelin is a synthetic hexapeptide analog of GHRP-6, meaning it was developed by modifying the GHRP-6 structure to enhance potency and stability. Like all GHRPs, it acts on the ghrelin receptor (also called the GH secretagogue receptor, or GHS-R) to stimulate GH release from the pituitary gland. Hexarelin was developed in the 1990s and has been studied in both animal models and human clinical research. It is one of the few GHRPs that has undergone formal clinical evaluation in humans, giving it a more robust research foundation than many newer peptides. What Does Research Show About GH Release Potency? Studies comparing GHRPs head-to-head consistently place Hexarelin at or near the top for GH-releasing potency. Research shows: Hexarelin produces among the largest acute GH spikes of any GHRP tested in research models. It shows activity in elderly subjects whose GH production has declined significantly — an area where some less potent GHRPs show diminished effects. Research suggests it stimulates both GH release and the release of GHRH from the hypothalamus, potentially amplifying its own effect through a dual mechanism. However, research also shows that Hexarelin is subject to desensitization with continuous administration — meaning the GH response diminishes with prolonged use in research models. This is a consistent finding that differentiates it from some other GHRPs in research protocol design. Cardiac Research Findings This is where Hexarelin research becomes particularly interesting. Studies have shown that Hexarelin exerts direct effects on cardiac tissue — independently of its GH-releasing activity. GH secretagogue receptors are expressed in the heart, and Hexarelin appears to bind to them directly. Research in rodent models of heart failure has shown that Hexarelin improves cardiac output and reduces cardiac remodeling. Studies have shown protective effects on cardiac tissue following ischemia-reperfusion injury (the damage that occurs when blood flow is restored after a blockage). Research suggests Hexarelin may reduce cardiomyocyte apoptosis (programmed cell death in heart muscle cells) under stress conditions. These cardiac findings are separate from its GH effects — researchers have shown that they persist even when GH release is blocked, confirming a direct cardiac mechanism. How Does It Compare to GHRP-6 and Ipamorelin? Compared to GHRP-6, Hexarelin is more potent but shares some of the cortisol and prolactin-elevating effects that make GHRP-6 less selective. Compared to ipamorelin, Hexarelin is significantly more potent but lacks ipamorelin’s selective GH-only profile. For researchers, the choice between them often comes down to whether raw GH-stimulating potency or receptor selectivity is the primary research priority. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. Get research-grade Hexarelin at peptivigor.com — see Hexarelin 5mg. Use code LABVIP1 at checkout to save 15% on your order.

MOTS-c: The Mitochondrial Peptide Researchers Are Calling a Game Changer MOTS-c is one of the newer peptides to enter the research spotlight, but it has generated an unusual level of excitement in a short time. Unlike most peptides, which are encoded in the nuclear genome, MOTS-c comes from a completely different place — the mitochondria. That alone makes it a fascinating research subject. What the studies show makes it even more interesting. What Is MOTS-c? MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c — a name that reflects its unusual origin. It is a 16-amino acid peptide encoded within the mitochondrial genome (specifically within the 12S rRNA gene), making it one of a small class of molecules known as mitochondria-derived peptides (MDPs). It was first described and characterized in 2015 by researchers at the USC Leonard Davis School of Gerontology, led by Dr. Pinchas Cohen. The discovery that mitochondria encode functional signaling peptides was itself a significant finding — and MOTS-c quickly emerged as the most biologically active of the MDPs identified so far. What Does the Research Show? Metabolic regulation: Research in rodent models has shown that MOTS-c improves metabolic function significantly. Studies report improvements in insulin sensitivity, glucose uptake, and fatty acid metabolism in animal subjects. Obesity and diet-induced metabolic disease: Studies show that MOTS-c-treated mice on high-fat diets gain significantly less weight than controls and maintain better metabolic health. This has made it a focus of metabolic disease research. Exercise performance: Research published in Nature Metabolism showed that MOTS-c levels increase in the blood of humans and mice during exercise — suggesting it may be part of the body’s natural response to physical activity. Studies in older mice showed that MOTS-c administration improved exercise capacity to levels similar to younger animals. Cellular stress response: MOTS-c appears to function as a stress-responsive molecule, activating AMPK — a master metabolic regulator — in response to metabolic stress conditions. Aging and longevity: Research has noted age-associated declines in MOTS-c levels, and studies in aged mice have shown that restoring those levels improves metabolic function and physical performance. Why Is It Considered Unique Among Peptides? The mitochondrial origin of MOTS-c is not just a biological curiosity — it changes how researchers think about it. Mitochondria are the energy centers of cells, and a peptide encoded there that signals back to the nucleus and regulates whole-body metabolism represents a fundamentally different kind of signaling molecule than most research peptides. MOTS-c is thought to function as part of a retrograde signaling system — mitochondria communicating their energy status to the rest of the cell and the body. That makes it relevant not just to metabolic disease research, but to any research program interested in how cells sense and respond to energy demands. Exercise Research Applications The finding that exercise raises MOTS-c levels has opened a new line of research. Scientists are now investigating whether MOTS-c mediates some of the systemic benefits of exercise — a concept sometimes described as finding the “exercise pill.” While no such thing exists, understanding how exercise generates molecular signals like MOTS-c is a major focus of exercise science research. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. Source research-grade MOTS-c at peptivigor.com — see MOTS-c 10mg. Use code LABVIP1 at checkout for 15% off your research order.

Epithalon: The Telomere Peptide at the Frontier of Longevity Research Few peptides carry as much weight in longevity research conversations as Epithalon. It sits at the intersection of telomere biology, pineal gland research, and anti-aging science — three areas that have each attracted enormous scientific attention on their own. Together, they make Epithalon one of the most discussed compounds in the longevity peptide category. What Is Epithalon? Epithalon (also spelled Epitalon) is a synthetic tetrapeptide — just four amino acids (Ala-Glu-Asp-Gly) — developed from research on epithalamin, a natural extract of the pineal gland. It was created by the late Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, beginning in the 1980s. The primary focus of Epithalon research has been on its ability to activate telomerase — the enzyme responsible for maintaining and lengthening telomeres. This positions it squarely in one of the most active areas of modern aging science. What Are Telomeres and Why Do They Matter? Telomeres are protective caps at the ends of chromosomes — often compared to the plastic tips on shoelaces. Every time a cell divides, telomeres shorten slightly. When they become too short, the cell stops dividing and enters a state called senescence. Shorter telomere length is strongly associated with biological aging, and researchers use telomere length as one marker of cellular age. Telomerase is the enzyme that can rebuild and extend telomeres — but it is largely inactive in most adult somatic cells. Research suggests that Epithalon may reactivate telomerase in aging cells, offering a potential mechanism for slowing cellular aging. What Do Studies Show? Telomerase activation: In vitro and animal studies have shown that Epithalon can activate telomerase and extend telomere length in aging cell lines and animal models. Lifespan extension in animal models: Several studies, including some conducted over extended periods in fruit flies and rodents, have reported increased maximum lifespan in subjects receiving Epithalon. Cancer research: Some studies have looked at Epithalon’s effects on tumor suppression in animal models, noting reductions in spontaneous tumor incidence. Melatonin and circadian regulation: As a pineal-derived peptide, Epithalon has been studied for its effects on melatonin production and circadian rhythm regulation in aging subjects. Antioxidant effects: Research has shown reductions in oxidative stress markers in animal models receiving Epithalon. The Russian Longevity Research Tradition Khavinson’s team published extensively on Epithalon over several decades, and some of the most robust long-term data comes from this body of work. While much of this research was conducted under Soviet and Russian research frameworks — meaning Western researchers have sometimes been cautious about direct replication — the core telomerase findings have attracted genuine international interest and independent study. For anti-aging researchers, Epithalon represents a peptide with a clearly defined molecular mechanism (telomerase activation), a real body of supporting research, and a unique origin in pineal gland biology that distinguishes it from most other longevity compounds. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. Source research-grade Epithalon at peptivigor.com — check out Epithalon 50mg. Use code LABVIP1 at checkout to get 15% off your order.

Melanotan II: The Tanning and Libido Peptide Generating Research Interest Melanotan II is one of the more provocative peptides in current research — it touches on skin, sexual function, and appetite in ways that make it genuinely interesting across multiple research disciplines. If you follow melanocortin receptor research, this one almost certainly has your attention. What Is Melanotan II? Melanotan II (MT-II) is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) — one of the body’s natural melanocortin peptides. It was originally developed at the University of Arizona in the 1980s as part of a research program aimed at finding a compound that could protect against UV-induced skin damage by promoting tanning without sun exposure. The peptide acts on multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R), which is why its research profile extends well beyond skin pigmentation. Each receptor is found in different tissues and mediates different effects — making Melanotan II a wide-reaching tool in melanocortin system research. What Does Research Show About Melanin Production and UV Protection? The original research goal was to activate MC1R in melanocytes — the skin cells that produce melanin. Studies show that Melanotan II does this effectively. In research models: Studies show significant increases in melanin production following Melanotan II administration. Research in fair-skinned animal models demonstrated increased pigmentation and, in some studies, reduced UV-induced DNA damage compared to controls. Researchers have used Melanotan II in models studying skin cancer risk factors, where UV protection is a key variable. Research on Libido and Melanocortin Receptors This is where Melanotan II generated some of its most surprising research findings. During early human trials, researchers observed unexpected effects on sexual arousal — specifically, spontaneous erections in male subjects. This led to a significant new research direction focused on MC4R and sexual function. Research suggests that melanocortin receptor activation — particularly MC4R in the central nervous system — plays a meaningful role in sexual arousal pathways. This finding eventually contributed to the development of PT-141 (bremelanotide), a related melanocortin peptide that has since received FDA approval for female sexual dysfunction. Melanotan II is still studied alongside PT-141 to better understand the melanocortin system’s role in sexual function. Why Researchers Study It Alongside PT-141 PT-141 was directly derived from Melanotan II research — it is essentially a cyclic form of MT-II designed to isolate the sexual function effects while reducing some of the side effects observed with MT-II (particularly nausea and blood pressure changes). Researchers studying the melanocortin pathway often study both compounds in parallel to understand the receptor selectivity differences between them and what that means for downstream effects. Melanotan II also continues to be studied for its effects on appetite regulation (through MC3R and MC4R) and metabolic function — another active area of melanocortin receptor research. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. Get research-grade Melanotan II at peptivigor.com — see Melanotan II 10mg. Use code LABVIP1 at checkout to save 15% on your order.